DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» MammaPrint
MammaPrint
Genetic Testing for Breast Cancer Recurrence and Predictive, MPM 33.0
Breast Cancer Recurrence Assay (Mammaprint®) Hs-197
The Case for Personalized Medicine
Gene Expression Profiling and Biomarker Testing for Breast Cancer
MP170 Gene Expression Profiling for Breast Cancer Treatment
Gene Expression Testing for Breast Cancer Prognosis AHS - M2020
(NCCN) Breast Cancer Clinical Practice Guidelines
(CANSA) Fact Sheet on Mammaprint Test
Understanding a Breast Cancer Diagnosis Breast Cancer Grade and Other Tests
Mammaprint Project ID: OTCA04 Project Description and Planning
Chemo Question Mindact Answer
Mammaprint® Test for Personalised Management of Adjuvant Chemotherapy Decisions in Early Breast Cancer a Rapid Assessment
Mammaprint Guides Treatment Decisions in Breast Cancer
Download Our Doctor Discussion Guide
Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes
Personalized Medicine: the Changing Landscape of Healthcare
Guide to the Mammaprint and Blueprint Summary of Results
Breast Cancer: a Molecularly Heterogenous Disease Needing Subtype-Specific Treatments
Top View
Personalized Medicine: Marking a New Epoch in Cancer Patient Management
Analysis of the Mammaprint Breast Cancer Assay in a Predominantly Postmenopausal Cohort Ben S
Mammaprint for Individualized Recurrence Risk Assessment and Treatment Recommendations for Early-Stage Breast Cancer Patients
The MINDACT Trial: the First Prospective Clinical Validation of A
Breast Cancer Test Suite Physician's Brochure
The Case for Personalized Medicine
5-Laura Vant Veer
70 Gene Mammaprint Assay Submitted by Agendia, Inc. on 05
Now That You Have Been Diagnosed with Breast Cancer, Learn How The
MINDACT Clinical Trial
The Case for Personalized Medicine
Mammaprint® and Blueprint® Breast Cancer Recurrence and Molecular Subtyping Kit – Package Insert
European Inter-Institutional Impact Study of Mammaprint
Physicians' Brochure Mammaprint FFPE
20200805 IKA Tamoxifen ESMO Poster Abstract Ultralow Mammaprint V8
Publishes Results of MINDACT Clinical Trial
Mammaprint® and Blueprint® Breast Cancer Recurrence and Molecular